Age | |
 Median, year | 61 |
 Range, year | 18-92 |
Gender | |
 Male, n(%) | 123 (60.3) |
 Female , n(%) | 81 (39.7) |
Median CLcra, mL/min | 88.7 |
NPb origin | |
 Cancer related NP, n(%) | 55 (27.0) |
 Chemotherapy related NP, n(%) | 24 (11.7) |
 Non-cancer related NP, n(%) | 125 (61.3) |
Regular strong opioid | |
 yes, n(%) | 36 (17.6) |
  -fentanyl, n | 17 |
  -oxycodone, n | 16 |
  -morphine, n | 3 |
  Median dosec (range), mg/day | 60 (15–300) |
 no, n(%) | 168 (82.4) |
Initial dose of pregabalin | |
 150 mg/day, n(%) | 124 (60.8) |
 75 mg/day, n(%) | 73 (35.8) |
 50 mg/day, n(%) | 3 (1.5) |
 25 mg/day, n(%) | 4 (1.9) |